ONLINE PRESS ROOM: NC-002 TRIAL LAUNCH

PRESS RELEASE

• TB Alliance Launches Combination Drug Trial, Establishes New Pathway to TB and MDR-TB Treatment

VIDEO

• Christine Lubinski Introduction
• Anthony Fauci Remarks
• Janet Woodcock Remarks
• Robert Clay Remarks
• Mel Spigelman Remarks and News Announcement
• Question and Answer session

PRESENTATIONS FROM LAUNCH EVENT

• Mel Spigelman's Presentation
• Dr. Anthony Fauci's Presentation

NC002 BACKGROUND

• Novel Regimens: New Momentum in Finding Novel TB Cures
• Accelerating New TB Regimens - Effective Coordination Across US Government

WORLD TB DAY PANEL EVENT AND NC002 ANNOUNCEMENT LAUNCH INFO

Monday, March 19, 2012 ** 1:30 – 3:00 PM
Barbara Jordan Conference Center, Kaiser Family Foundation, 1330 G Street NW, Washington DC

• Media Advisory: TB Alliance to Launch New Combination Drug Trial
• DRAFT Event Agenda

SPEAKER BIOGRAPHIES

• Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases
• Dr. Mel Spigelman, President and CEO, Global Alliance for TB Drug Development
• Dr. Janet Woodcock, Director, US Food and Drug Administration’s Center for Drug Evaluation and Research
• Dr. Robert Clay, Deputy Assistant Administrator, US Agency for International Development’s Global Health Bureau
• Christine Lubinski, Vice President for Global Health, Infectious Diseases Society of America

VIDEOS

• Dr. Anthony Fauci Invites you to Cure All
• CPTR and the Promise of Regimen-Based Drug Development
• Patient Story: A 7 Year-Old Battles MDR-TB
• Lessons Learnt from MDR-TB Outbreak in New York City

PICTURES:

• Download pictures, captions, and photo credits for media use